{"id":"NCT03849560","sponsor":"NPO Petrovax","briefTitle":"Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers","officialTitle":"A Multicenter, Double-Blind, Randomized, Parallel Group Study of Safety, Reactogenicity, Immunogenicity, and Efficacy of Quadrivalent Influenza Vaccine Grippol Quadri and Trivalent Influenza Vaccine Grippol Plus in Volunteers.","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-11","primaryCompletion":"2017-06","completion":"2017-08","firstPosted":"2019-02-21","resultsPosted":"2024-11-04","lastUpdate":"2024-11-04"},"enrollment":612,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Grippol® Quadri","otherNames":[]},{"type":"BIOLOGICAL","name":"Grippol® Plus, trivalent (Yamagata lineage)","otherNames":[]},{"type":"BIOLOGICAL","name":"Grippol® Plus, trivalent (Victoria lineage)","otherNames":[]}],"arms":[{"label":"Grippol® Quadri","type":"EXPERIMENTAL"},{"label":"Grippol® Plus, trivalent (Yamagata lineage)","type":"ACTIVE_COMPARATOR"},{"label":"Grippol® Plus, trivalent (Victoria lineage)","type":"ACTIVE_COMPARATOR"}],"summary":"The aim of the study to assess the safety, reactogenicity, immunogenicity, and efficacy of quadrivalent inactivated subunit influenza vaccine Grippol® Quadri (NPO Petrovax Pharm, LLC, Russia) versus trivalent inactivated polymer-subunit vaccine Grippol® Plus (NPO Petrovax Pharm, LLC, Russia) in subjects from 18 to 60 years old.","primaryOutcome":{"measure":"Percent of Subjects Achieving Seroconversion Increased More Than 4-fold Versus Baseline for Antigens: Influenza Virus Type А - H1N1, Influenza Virus Type А - H3N2, Influenza Virus Type В - Yamagata and Victoria Lineage","timeFrame":"Day 21 after immunization (Visit 7)","effectByArm":[{"arm":"Grippol® Quadri","deltaMin":133,"sd":null},{"arm":"Grippol® Plus, Trivalent (Yamagata Lineage)","deltaMin":127,"sd":null},{"arm":"Grippol® Plus, Trivalent (Victoria Lineage)","deltaMin":126,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":null},{"comp":"OG000 vs OG001 vs OG002","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":8},"locations":{"siteCount":3,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":205},"commonTop":["Upper respiratory tract infection","Headache","Rhinorrhea","Oral herpes","Rhinitis"]}}